ENGLEWOOD, CO — (Marketwire) — 11/04/09 — Biomedical Technology Solutions Holdings, Inc. (”BMTS” or the “Company”; www.bmtscorp.com) (OTCBB: BMTL) is pleased to announce the introduction of the Demolizer® II System into the Geisinger Health organization for the onsite treatment of biomedical waste.

The Geisinger Health System is one of the nation’s leading fully integrated health services organizations. Founded in 1915, Geisinger is a physician-led health care system, dedicated to health care, education, research and service spanning 43 counties in Pennsylvania and serving over 2.6 million people in primarily rural communities.

The Demolizer® II is a safe and simple biomedical waste treatment system ideally suited to meet the unique needs of clinics in rural areas where the cost, both financial and environmental, of traditional transport and offsite disposal can be prohibitive. Cost savings from adoption of the Demolizer® II are expected to be significant. More importantly, the Demolizer® II

Worldwide studies have proven that high-risk medication compounding errors in pharmacies continue to cause significant harm to patients and monetary loss to hospitals. Today, CDEX, Inc. announced that Geisinger Medical Center has joined a growing list of world-class hospitals that are proactively addressing this issue by selecting the ValiMed™ Medication Safety System to assure the “Right Drug at the Right Dose” every time.

“After reading the University of Michigan Health System study that documented ValiMed’s identification of five major medical mistakes over an 18 month period at one hospital, I knew that we needed to bring that technology in-house,” stated John Jones, Geisinger Vice President, System Therapeutics. “We purchased two ValiMed units to provide additional assurance of accuracy of our compounding practices.”

“We are honored that Geisinger Medical Center selected ValiMed as part of its Medication Safety Program and look forward to working with John and his staff in integrating